Cancer Immunotherapy
2 stories
-
healthAI Transforms Precision Oncology Through Advanced mRNA Engineering
New research details how artificial intelligence optimizes cancer vaccine development, targeting neoantigens and delivery mechanisms for personalized therapy.
-
healthPersonalized mRNA Vaccines Show Durable T Cell Immunity Against TNBC
New research demonstrates individualized mRNA neoantigen vaccines successfully induce robust and lasting T cell responses in patients with triple-negative breast cancer (TNBC), offering a promising therapeutic avenue.